From IgE to Omalizumab
Toshiaki Kawakami and Ulrich Blank
J Immunol December 1, 2016, 197 (11) 4187-4192; DOI: https://doi.org/10.4049/jimmunol.1601476
Toshiaki Kawakami
*Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
†Department of Dermatology, University of California San Diego School of Medicine, La Jolla, CA 92093;
Ulrich Blank
‡INSERM Unité 1149, Centre de Recherche sur I’Inflammation, 75018 Paris, France;
§CNRS Equipe de Recherche Labellisée 8252, 75018 Paris, France;
¶Université Paris Diderot, Sorbonne Paris Cité, Faculté de Médecine, Site Xavier Bichat, 75018 Paris, France; and
‖Inflamex Laboratory of Excellence, Xavier Bichat Site, 75018 Paris, France
In this issue
From IgE to Omalizumab
Toshiaki Kawakami, Ulrich Blank
The Journal of Immunology December 1, 2016, 197 (11) 4187-4192; DOI: 10.4049/jimmunol.1601476